Although the sensitivity of exfoliative cytopathology in the diagnosis of bronchogenic carcinoma has been reported to be as low as 44 per cent,' most cytologists find malignant cells in the sputum or bronchial aspirates from three of every four patients with lung cancer, more or less.24 Most reports contain selected series of cases, since patients who have not had cytologic examinations usually are excluded; likewise patients in whom the quantity or quality of the smears is not adequate also may be omitted.
Thus it is difficult to ascertain the full role of exfoliative cytodiagnosis of carcinoma of the lung in routine hospital practice. The purpose of this study was to determine this role by a retrospective analysis.
Material and Method
The results of all types of microscopic diagnostic modalities utilized in 152 consecutive unselected and histologically proved bronchogenic carcinomas in patients admitted to the Veterans Administration Hospi tal at Ann Arbor, over a five-year period (1954) (1955) (1956) (1957) (1958) (1959) were reviewed and tabulated.
The series included six cases in which the neoplasm was an unexpected or incidental finding at necropsy thereby precluding ante mortem diagnostic studies.
One hundred and twenty-six (82.9 per cent) of the patients had some form of cytologic smear examination-sputum, bronchial aspirate, or pleu ral fluid. Usually multiple specimens were examined; the mean was about three specimens per patient.
However, in many instances the cytologic study was limited to the examination of a single specimen.
Four smears were prepared from each specimen and were processed in accordance with the standard Papanicolaou technique. Ninty-six (63.2 per cent) of the patients were subjected to broncho scopy; for the purpose of this study, bronchoscopy was interpreted as positive only when a histologic diagnosis of carcinoma was made by bronchial biopsy.
Eighty-nine patients (58.6 per cent) had anterior scalene lymph node biopsies, performed according to the technique of Daniels.7 The lymph nodes were obtained from the right side when a lesion was present in the right lung or the left lower lobe; left scalene lymph node biopsies were reserved for lesions in the left upper lobe or lingular segments. The number of lymph nodes in these specimens varied from 0 to 20 with a mean of six. Histologic examinations of tissue from suspected metastases were made in 18 cases. These tissues included lymph nodes (other than scalene), liver, skin, bone, or central nervous system. Thus a total of Frorn The practical value of cytopathologic smear diagnosis is shown in Table 2 . In 38 cases, positive smears of sputum, bronchial aspirates, or pleural fluid provided the sole microscopic evidence of lung cancer prior to thoracotomy or necropsy. This is also illustrated in Figures 1 and 2 . If the cytologic results were eliminated from the diagnostic studies, only 52 per cent of the patients would have had a microscopic diagnosis prior to thoracotomy or necropsy, whereas the combined cytopathologic and histopathologic studies increased this diagnostic sensitivity to over 75 per cent ( Figure 1 ). The contrast is even more striking in the 50 resected cases where the percentage of preoperative microscopic diagnoses was doubled by the addition of the cytologic investigations ( Figure 2 ). Only 28 per cent of the pulmonary resections were undertaken without a pre operative microscopic diagnosis having been made.
The significance of the location of the neoplasm in the accuracy of cytologic diagnosis is given in Table 3 . Positive smears were obtained from 39 of 56 (69.6 per cent) cancers in upper lobes and 29 of 35 (86.4 per cent) in lower lobes.
The sensitivity of cytologic diagnosis varied inversely with the dis tance of the neoplasm from the carina (Table 3 ) although the size of the tumor proved to be a modifying factor. Less than 50 per cent of the small peripheral carcinomas were associated with positive smears, in contrast to 14 of the 15 peripheral carcinomas which were over five centi meters in size ( ence on the cytologic diagnosis of hilar carcinomas. In fact, the larger hilar neoplasms were detected slightly less frequently, probably because of the greater incidence of bronchial obstruction.
Discussion
The practical value of a diagnostic modality may be measured better in an un selected series such as this rather than by the determination of its sensitivity under ideal circumstances.
For example, the sensitivity of bronchoscopic biopsy of visible lesions of the bronchi is high, but many lesions are not visible, or are beyond the reach of the bronchoscope, and bronchoscopy is often omitted because of roentgeno graphic demonstration of subpleural location of the neoplasm or because of medical or structural contraindications. Similarly, if the sensitivity of smear diagnosis of exfoliated material is determined on the basis of the number of patients with broncho genic carcinoma who have multiple examinations of adequate specimens of sputum or bronchial aspirates, the great majority of such patients wifi be found to have malignant cells in the smears. Nevertheless, some patients are unable or unwilling to raise sputum, or their sputum may not include bronchial secretions.
This study indicates the great impact of exfoliative cytopathology on the routine diagnosis of bronchogenic carcinoma. The number of patients who had positive smears exceeded the combined results of all methods of histologic diagnosis, exclusive of thoracotomy and necropsy. Of greater significance is the finding that 25 per cent of the patients had positive smears as the only microscopic proof of carcinoma prior to thoracotomy or necropsy. The review of the resectable cases is even more significant and here too the diag nostic potentialities of exfoliative cytopathology are demonstrated.
In the absence of cytologic examination only about one-third (36 per cent) of the patients with resected neoplasms in this series would have had a microscopic diagnosis of carcinoma prior to operation.
The examination of smears of sputum or bronchial aspirates doubled this number so that almost three-fourths (72 per cent) of the patients had proved carcinoma prior to thoracotomy.
The full potentialities of smear diagnosis were not realized In this series of patients. Twenty-six patients did not have the benefit of cytologic examination. Admlttediy, in some of these cases the examination was not necessary, the diagnosis having been established by other means. However, In some Instances the patients were unable to raise sputum; this failure to raise sputum occurred prior to the use of aerosol sputum Induction, which has practically eliminated unsatisfactory sputum specimens.8'9 In some instances, the patient died before specimens could be obtained. Among the 26 patientswho had falsenegativecytologic reports, were many patientswho had only one specimen examined. These Incompletecytologic studieswere occasionedby mis understandingon the part of the medical or nursing staff, death,or the establish ment of diagnosis by another means. 3. In 25 per cent of the patients, exfoliative cytopathology provided the only micro scopic evidence of carcinoma prior to thoracotomy or necropsy. 4. Exfoliative cytodiagnosis increased the prethoracotomy microscopic diagnosis of carcinoma of the lung from 36 per cent to 72 per cent in 50 patients whose carcinomas were resected.
5. That cytologic diagnosis of carcinoma of lower lobes was 16.8 per cent greater than that of upper lobes. The frequency of malignant cells in sputum or bronchial aspirates varied inversely with the distance of the neoplasm from the carina, except for peripheral tumors over five centimeters in size which were detected as frequently as were those in the hilar areas. RESUMEN 1. Entre 152 enfermos no escogidos, con carcinoma pulmonar demostrado histolÃ³gi camente, incluyendo seis con neoplasias no sospechosas hasta la necropsia, se sentÃ³ un diagnOstico por la citopatologia exfoliativa en 100 casos. Veintiseis de los 152 en fermos no se examinaron la tÃ©cnica del frotis y 26 tuviero frotis negativos. 2. El diagnÃ³stico citolÃ³gico positivo se hizo mas frecuente (65.8 por clento) que el diagnÃ³stico histolÃ³gico antes de la toracotomfa (52 por ciento) usando todas las formas de biopsia.
3. En 25 por ciento de los enfermos la citologia exfollativa proporcionÃ³ la iiica evidencia microscÃ³pica antes de la toracotomia o necropsia. 4. El citodiagnÃ³stico exioliativo aumentÃ³ el nÃ¼mero de diagnOsticos microscÃ³picos antes de la toracotomi a por carcinoma del pulmÃ³n de 36 por ciento a 72 por ciento en 50 enfermos cuyo carcinoma se resecÃ³.
5. El diagnÃ³stico citolOgico del carcinoma de los lObulos inferiores fuÃ©16.8 por ciento mayor que el de los lObulos superiores.
La frequenciade celdillas malignas en elesputoo productosde aspiraciÃ³n bronquial variO en proporciÃ³n inversa con la distancia de la carina, excepto para los tumores perifÃ©ricos de mas de 5 cms. que se revelaron tan frecuentemente como los hiliares. RESUME 1. Pour 152 malades non sÃ©lectionnÃ©s chez lesquels un cancer pulmonaire a Ã©tÃ© mis en evidence par l'histologie, y compris six cas de nÃ©oplasies insoupÃ §onnÃ©esdÃ© couvertes a l'autopsie, le diagnostic microscopique fut Ã©tablipar la cytologic dans 100 cas. 26 des 152 malades ne furent pas examines selon la technique des frottis, et 26 eurent des frottis nÃ©gatlfs.
2. Le diagnostic cytologique a Ã©tÃ© plus frÃ©quemment positif (65.8%) que le diag nostic histologique avant thoracotomie (52%) tous les types de mÃ©thodes biopsiques classiques ayant Ã©tÃ© utiisÃ©s.
3. Chez 25% des malades, la cytologic fournit la seule preuve microscopique de cancer avant la thoracotomie ou l'autopsie. 4. Le cytodiagnostic a permis que le diagnostic microscopique avant thoracotomie pour cancer pulmonaire puisse Ãªtre fait dans une proportion qui a passÃ©de 36 a 72% chez 50 malades ayant subi une exÃ©rÃ¨se pour cancer.
5. Le diagnostic cytologique de cancer des lobes infÃ©rleurs se montra plus Ã©levÃ© de 16.8% que celui des lobes supÃ©rieurs. La frÃ©quence des cellules malignes dans l'ex pectoration ou l'aspiration bronchique varia en raison inversa de la distance du nÃ©o plasme a la carÃ¨ne, sauf pour les tumeurs pÃ©riphÃ©riquesde plus de cinq centimetres qui furent dÃ©tectÃ©es aussi frÃ©quemment que le furent celles des zones hilaires. 
